Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Claimed Company
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions read more
Karyopharm Therapeutics Awards 2020
Karyopharm Therapeutics won 4 awards in 2020. In 2020, Karyopharm Therapeutics won for Best Company Compensation, Best Company Happiness, Best Professional Development 2020 and Best Leadership Teams 2020. Based on 2,628 ratings and 90 participants, employees at Karyopharm Therapeutics are very satisfied with their work experience. The overall culture score, 79/100 or A-, incorporates employee ratings based on their feedback on the Perks And Benefits, Team, Leadership and more.
Comparably Awards are provided yearly to top performing company cultures based on real feedback from their employees.
Best Company Compensation 2020 (Small & Midsize Companies)Karyopharm TherapeuticsBest Company Compensation
Best Company Happiness 2020 (Small & Midsize Companies)Karyopharm TherapeuticsBest Company Happiness
Best Professional Development 2020 (Small & Midsize Companies)Karyopharm TherapeuticsBest Professional Development 2020
Best Leadership Teams 2020 (Small & Midsize Companies)Karyopharm TherapeuticsBest Leadership Teams 2020
Help Your Company Win 2025 Awards
Anonymously rate your experience & help make Karyopharm Therapeutics a better place to work.
Awards Press for Karyopharm Therapeutics
×